Northern Trust’s AMAG Pharmaceuticals AMAG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-440,483
| Closed | -$4.14M | – | 4453 |
|
|
2020
Q3 | $4.14M | Sell |
440,483
-25,794
| -6% | -$245K | ﹤0.01% | 2652 |
|
|
2020
Q2 | $3.57M | Sell |
466,277
-14,915
| -3% | -$114K | ﹤0.01% | 2727 |
|
|
2020
Q1 | $2.97M | Buy |
481,192
+2,153
| +0.4% | +$19K | ﹤0.01% | 2620 |
|
|
2019
Q4 | $5.83M | Sell |
479,039
-4,176
| -0.9% | -$45.6K | ﹤0.01% | 2495 |
|
|
2019
Q3 | $5.58M | Buy |
483,215
+36,783
| +8% | +$387K | ﹤0.01% | 2485 |
|
|
2019
Q2 | $4.46M | Buy |
446,432
+14,226
| +3% | +$153K | ﹤0.01% | 2621 |
|
|
2019
Q1 | $5.57M | Sell |
432,206
-35,508
| -8% | -$529K | ﹤0.01% | 2501 |
|
|
2018
Q4 | $7.1M | Sell |
467,714
-3,136
| -0.7% | -$59.8K | ﹤0.01% | 2296 |
|
|
2018
Q3 | $9.42M | Buy |
470,850
+10,141
| +2% | +$231K | ﹤0.01% | 2293 |
|
|
2018
Q2 | $8.98M | Buy |
460,709
+2,264
| +0.5% | +$50.1K | ﹤0.01% | 2331 |
|
|
2018
Q1 | $9.24M | Buy |
458,445
+4,468
| +1% | +$75.6K | ﹤0.01% | 2219 |
|
|
2017
Q4 | $6.01M | Sell |
453,977
-9,283
| -2% | -$140K | ﹤0.01% | 2494 |
|
|
2017
Q3 | $8.55M | Sell |
463,260
-1,387
| -0.3% | -$25.9K | ﹤0.01% | 2300 |
|
|
2017
Q2 | $8.55M | Buy |
464,647
+26,725
| +6% | +$530K | ﹤0.01% | 2278 |
|
|
2017
Q1 | $9.88M | Buy |
437,922
+6,638
| +2% | +$159K | ﹤0.01% | 2133 |
|
|
2016
Q4 | $15M | Buy |
431,284
+7,488
| +2% | +$224K | ﹤0.01% | 1816 |
|
|
2016
Q3 | $10.4M | Buy |
423,796
+11,942
| +3% | +$298K | ﹤0.01% | 2046 |
|
|
2016
Q2 | $9.85M | Sell |
411,854
-15,588
| -4% | -$357K | ﹤0.01% | 2038 |
|
|
2016
Q1 | $10M | Buy |
427,442
+10,637
| +3% | +$252K | ﹤0.01% | 1973 |
|
|
2015
Q4 | $12.6M | Sell |
416,805
-1,891
| -0.5% | -$61.1K | ﹤0.01% | 1835 |
|
|
2015
Q3 | $16.6M | Buy |
418,696
+60,054
| +17% | +$3.73M | 0.01% | 1629 |
|
|
2015
Q2 | $24.8M | Buy |
358,642
+70,377
| +24% | +$4.43M | 0.01% | 1420 |
|
|
2015
Q1 | $15.8M | Buy |
288,265
+32,913
| +13% | +$1.57M | ﹤0.01% | 1760 |
|
|
2014
Q4 | $10.9M | Sell |
255,352
-2,904
| -1% | -$105K | ﹤0.01% | 1994 |
|
|
2014
Q3 | $8.24M | Sell |
258,256
-10,536
| -4% | -$225K | ﹤0.01% | 2172 |
|
|
2014
Q2 | $5.57M | Sell |
268,792
-27,530
| -9% | -$509K | ﹤0.01% | 2438 |
|
|
2014
Q1 | $5.73M | Sell |
296,322
-28,174
| -9% | -$599K | ﹤0.01% | 2468 |
|
|
2013
Q4 | $7.88M | Buy |
324,496
+5,338
| +2% | +$126K | ﹤0.01% | 2244 |
|
|
2013
Q3 | $6.85M | Sell |
319,158
-2,915
| -0.9% | -$68.9K | ﹤0.01% | 2280 |
|
|
2013
Q2 | $7.17M | Buy |
+322,073
| New | +$7.1M | ﹤0.01% | 2166 |
|
Northern Trust's AMAG Position: Q4 2020 in Review
Northern Trust sold out of AMAG Pharmaceuticals (AMAG) in Q4 2020, closing a stake of 440,483 shares — an estimated $4.14M sold.
Northern Trust first reported a position in AMAG in Q2 2013 and held it in 30 quarters. The position peaked at $24.8M in Q2 2015. 1 fund tracked by Wall St. Rank holds AMAG as of Q4 2020.
- Northern Trust reported no remaining AMAG Pharmaceuticals position as of Q4 2020 after selling out during the quarter.
- Northern Trust sold 440,483 AMAG Pharmaceuticals shares in Q4 2020, an estimated $4.14M.
- Northern Trust first reported a position in AMAG Pharmaceuticals in Q2 2013 and held it in 30 quarters.
- Northern Trust's AMAG Pharmaceuticals position peaked at $24.8M in Q2 2015.
- 1 fund tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q4 2020.
Based on Northern Trust's 13F filing for Q4 2020, filed 11 Feb 2021.